June 30th, 2016
•This article describes the high-throughput assay that has been successfully established to screen large libraries of small molecules for their potential ability to manipulate cellular levels of cyclic di-GMP in Pseudomonas aeruginosa, providing a new powerful tool for antibacterial drug discovery and compound testing.
Tags
Related Videos
Pseudomonas aeruginosa and Saccharomyces cerevisiae Biofilm in Flow Cells
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis and Mycobacterium marinum Infection as a Model for Drug Discovery
Pseudomonas aeruginosa Induced Lung Injury Model
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate
A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved